معرفی
Sudhir Perincheri, MD, PhD, is an Assistant Professor of Pathology at Yale School of Medicine and serves as Director of Digital Pathology. He completed his residency in Anatomic Pathology/Clinical Pathology as well as fellowship training in hematopathology, renal and genitourinary pathology in the Departments of Pathology and Laboratory Medicine at Yale.
Dr. Perincheri's research focuses on the application of emerging tools in anatomic pathology, with particular expertise in digital pathology. His work bridges clinical pathology with technological innovations, especially in the transition from traditional glass slides to digital imaging systems that may eventually incorporate artificial intelligence algorithms for more accurate disease diagnosis.
His research portfolio shows a strong emphasis on renal pathology, transplant pathology, and genitourinary tumors. Analysis of his recent publications reveals a consistent focus on glomerular diseases, mechanisms of transplant rejection, and diagnostic innovations in hematopathology. His work often involves collaborative research with other Yale faculty in applying advanced imaging techniques like MultiPhoton Microscopy to renal and prostate pathology.
Scientific Recognition
- Postdoctoral Fellowship Award from Juvenile Diabetes Research Foundation (2006)
Dr. Perincheri maintains active clinical responsibilities, regularly diagnosing complex cases involving blood cancers, kidney disorders, and genitourinary malignancies. His role as Director of Digital Pathology places him at the forefront of technological transformation in the field, working on the development and implementation of digital imaging systems that could revolutionize how pathology is practiced.
He serves on several professional committees including the ECOG-ACRIN Multiple Myeloma Committee, ECOG-ACRIN Laboratory Science and Pathology Committee, Medical Record and Clinical Information Committee, and the College of American Pathology Digital and Computational Pathology Committee. These roles demonstrate his leadership in advancing pathology practice standards and digital transformation in the field.
